MOG and Myelopathy: In this case, MOG-IgG was detected using a cell-based assay at a low positive titer (1:10), which was interpreted as clinically meaningful in the context of recurrent optic neuritis, MRI-negative myelopathy, and recent corticosteroid exposure, which is recognized to reduce circulating antibody titers.